Efficacy of imiquimod 5% cream as first-line management in cutaneous leishmaniasis caused by Leishmania mexicana
Rev. Soc. Bras. Med. Trop
;
54: e0305-2020, 2021. graf
Article
in English
| LILACS
| ID: biblio-1155563
ABSTRACT
Abstract Cutaneous leishmaniasis (CL) involves several differential diagnoses as it lacks a gold standard diagnostic test. Its diagnosis is easier in endemic regions; however, many cases come from travelers to endemic areas. A 22-year-old patient, who had recently visited Oaxaca, Mexico, developed two asymptomatic ulcers weeks later on the left auricle and the nose. Leishmania mexicana was identified using polymerase chain reaction. The patient was treated with imiquimod 5% cream three times/week, providing favorable results after 12 weeks, without relapse 2 months after therapy. To our knowledge, this is the first case of CL due to L. mexicana effectively treated with imiquimod.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Leishmania mexicana
/
Leishmaniasis, Mucocutaneous
/
Leishmaniasis, Cutaneous
Type of study:
Prognostic study
Limits:
Humans
Country/Region as subject:
Mexico
Language:
English
Journal:
Rev. Soc. Bras. Med. Trop
Journal subject:
Tropical Medicine
Year:
2021
Type:
Article
Affiliation country:
Mexico
Institution/Affiliation country:
Hospital General de México/MX
/
Instituto Nacional de Medicina Genómica/MX
/
Universidad Nacional Autónoma de México/MX
Similar
MEDLINE
...
LILACS
LIS